Research investigating GLP-1 receptor agonists for substance use disorders is rapidly expanding, with studies examining multiple substance classes and patient populations
The FDA-approved prescribing information for tirzepatide states that the medication can be administered at any time of day, with or without meals, providing significant flexibility for patients
While free radicals are essential for certain physiological processes, such as cell signaling and immune defense, their overproduction can disrupt the delicate balance between oxidants and antioxidants, leading to oxidative stress
Step 1: Start with a Low Dose Your provider will typically start you on a very low dose of medication and gradually increase it
Current GLP-1 medications include: Wegovy (semaglutide) licensed for weight loss Ozempic and Rybelsus (semaglutide) licensed for type 2 diabetes Mounjaro (tirzepatide) licensed for both diabetes and weight loss Liraglutide varies by brand
Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice